Jane J. Zara

Array ( [id] => 5136476 [patent_doc_number] => 20070078105 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-05 [patent_title] => 'Methods and means for obtaining modified phenotypes' [patent_app_type] => utility [patent_app_number] => 11/607062 [patent_app_country] => US [patent_app_date] => 2006-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 18213 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0078/20070078105.pdf [firstpage_image] =>[orig_patent_app_number] => 11607062 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5080260 [patent_doc_number] => 20070123484 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-31 [patent_title] => 'DOUBLE STRAND COMPOSITIONS COMPRISING DIFFERENTIALLY MODIFIED STRANDS FOR USE IN GENE MODULATION' [patent_app_type] => utility [patent_app_number] => 11/565773 [patent_app_country] => US [patent_app_date] => 2006-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 43771 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0123/20070123484.pdf [firstpage_image] =>[orig_patent_app_number] => 11565773 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5028883 [patent_doc_number] => 20070270330 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-22 [patent_title] => 'PREVENTING AIRWAY MUCUS PRODUCTION BY ADMINISTRATION OF EGF-R ANTAGONISTS' [patent_app_type] => utility [patent_app_number] => 11/564190 [patent_app_country] => US [patent_app_date] => 2006-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 33300 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0270/20070270330.pdf [firstpage_image] =>[orig_patent_app_number] => 11564190 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7688889 [patent_doc_number] => 20070105809 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-10 [patent_title] => 'Modulators of coagulation factors with enhanced stability' [patent_app_type] => utility [patent_app_number] => 11/605712 [patent_app_country] => US [patent_app_date] => 2006-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 27648 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20070105809.pdf [firstpage_image] =>[orig_patent_app_number] => 11605712 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6433521 [patent_doc_number] => 20100278797 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-04 [patent_title] => 'Pharmaceutical Composition and Method for Regulating Abnormal Cellular Proliferation' [patent_app_type] => utility [patent_app_number] => 12/085023 [patent_app_country] => US [patent_app_date] => 2006-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 25335 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0278/20100278797.pdf [firstpage_image] =>[orig_patent_app_number] => 12085023 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4903938 [patent_doc_number] => 20080113351 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-15 [patent_title] => 'Polynucleotides for causing RNA interference and method for inhibiting gene expression using the same' [patent_app_type] => utility [patent_app_number] => 11/598052 [patent_app_country] => US [patent_app_date] => 2006-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 40 [patent_figures_cnt] => 40 [patent_no_of_words] => 35007 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20080113351.pdf [firstpage_image] =>[orig_patent_app_number] => 11598052 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5253242 [patent_doc_number] => 20070134698 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-14 [patent_title] => 'siRNA targeting histamine receptor H1' [patent_app_type] => utility [patent_app_number] => 11/595698 [patent_app_country] => US [patent_app_date] => 2006-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 34886 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0134/20070134698.pdf [firstpage_image] =>[orig_patent_app_number] => 11595698 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4825074 [patent_doc_number] => 20080124379 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-29 [patent_title] => 'Compositions and methods for making therapies delivered by viral vectors reversible for safety and allele-specificity' [patent_app_type] => utility [patent_app_number] => 11/592812 [patent_app_country] => US [patent_app_date] => 2006-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8549 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20080124379.pdf [firstpage_image] =>[orig_patent_app_number] => 11592812 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5100764 [patent_doc_number] => 20070184026 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-09 [patent_title] => 'Methods, Agents, and Compound Screening Assays for Inducing Differentiation of Undifferentiated Mammalian Cells into Osteoblasts' [patent_app_type] => utility [patent_app_number] => 11/551744 [patent_app_country] => US [patent_app_date] => 2006-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 17286 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0184/20070184026.pdf [firstpage_image] =>[orig_patent_app_number] => 11551744 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6576184 [patent_doc_number] => 20100129460 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-27 [patent_title] => 'COMPOUNDS AND METHODS FOR PEPTIDE RIBONUCLEIC ACID CONDENSATE PARTICLES FOR RNA THERAPEUTICS' [patent_app_type] => utility [patent_app_number] => 12/445575 [patent_app_country] => US [patent_app_date] => 2006-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 25247 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0129/20100129460.pdf [firstpage_image] =>[orig_patent_app_number] => 12445575 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 307458 [patent_doc_number] => 07531524 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-05-12 [patent_title] => 'Modulators of coagulation factors with enhanced stability' [patent_app_type] => utility [patent_app_number] => 11/546190 [patent_app_country] => US [patent_app_date] => 2006-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 19 [patent_no_of_words] => 27258 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/531/07531524.pdf [firstpage_image] =>[orig_patent_app_number] => 11546190 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7518712 [patent_doc_number] => 07972813 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-07-05 [patent_title] => 'Tetrodotoxin-resistant sodium channel alpha subunit' [patent_app_type] => utility [patent_app_number] => 11/540143 [patent_app_country] => US [patent_app_date] => 2006-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22977 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/972/07972813.pdf [firstpage_image] =>[orig_patent_app_number] => 11540143 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8410303 [patent_doc_number] => 08273700 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-09-25 [patent_title] => 'Methods and compositions for treatment of cystic fibrosis' [patent_app_type] => utility [patent_app_number] => 11/992799 [patent_app_country] => US [patent_app_date] => 2006-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 27736 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11992799 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5204522 [patent_doc_number] => 20070026002 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-01 [patent_title] => 'Inhibitors of angiopoietin-like 4 protein, combinations, and their use' [patent_app_type] => utility [patent_app_number] => 11/540884 [patent_app_country] => US [patent_app_date] => 2006-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 37809 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0026/20070026002.pdf [firstpage_image] =>[orig_patent_app_number] => 11540884 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5242185 [patent_doc_number] => 20070020679 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-25 [patent_title] => 'Modulation of HIF1alpha and HIF2alpha expression' [patent_app_type] => utility [patent_app_number] => 11/527876 [patent_app_country] => US [patent_app_date] => 2006-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34939 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20070020679.pdf [firstpage_image] =>[orig_patent_app_number] => 11527876 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5079170 [patent_doc_number] => 20070122394 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-31 [patent_title] => 'Compositions and Methods for Liver Growth and Liver Protection' [patent_app_type] => utility [patent_app_number] => 11/535049 [patent_app_country] => US [patent_app_date] => 2006-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 23629 [patent_no_of_claims] => 79 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0122/20070122394.pdf [firstpage_image] =>[orig_patent_app_number] => 11535049 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5057693 [patent_doc_number] => 20070060615 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-15 [patent_title] => 'Method of Modulating Apoptosis Through Modulation of E2F1' [patent_app_type] => utility [patent_app_number] => 11/534459 [patent_app_country] => US [patent_app_date] => 2006-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 6088 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0060/20070060615.pdf [firstpage_image] =>[orig_patent_app_number] => 11534459 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5242832 [patent_doc_number] => 20070021327 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-25 [patent_title] => 'Methods and compositions for treatment of tumors using nucleic acid ligands to platelet-derived growth factor' [patent_app_type] => utility [patent_app_number] => 11/518321 [patent_app_country] => US [patent_app_date] => 2006-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6604 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20070021327.pdf [firstpage_image] =>[orig_patent_app_number] => 11518321 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6638189 [patent_doc_number] => 20100035963 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-11 [patent_title] => 'Oligoribonucleotides and Methods of use Thereof for Treatment of Cardiovascular Disease' [patent_app_type] => utility [patent_app_number] => 11/991881 [patent_app_country] => US [patent_app_date] => 2006-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 102919 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0035/20100035963.pdf [firstpage_image] =>[orig_patent_app_number] => 11991881 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 43382 [patent_doc_number] => 07776595 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-08-17 [patent_title] => 'Methods for genetic modification of hematopoietic progenitor cells and uses of the modified cells' [patent_app_type] => utility [patent_app_number] => 11/506722 [patent_app_country] => US [patent_app_date] => 2006-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 23 [patent_no_of_words] => 34222 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 250 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/776/07776595.pdf [firstpage_image] =>[orig_patent_app_number] => 11506722 [rel_patent_id] =>[rel_patent_doc_number] =>)